Efficacy of Varenicline for Smokeless Tobacco Use in India

ational Institute on Drug Abuse R DA0 sites237 target enrollmentTBD

Overview

No summary available.

Registry

who.int

Start Date

TBD

End Date

October 31, 2013

Last Updated

3 years ago

Study Type

Interventional

Sponsor

ational Institute on Drug Abuse R DA

•) Males and females over age 18 who have used smokeless tobacco every day for the past year (confirmed with urinary cotinine);
•b) Residing within 100 km of New Dehli for the next 4 months
•c) Interested in quitting use of smokeless tobacco.

•Participants will be ineligible for the trial if they:
•1\) are currently enrolled or plan to enroll in another tobacco cessation program in the next 4 months;
•2\)plan to use other smoking cessation treatments in the next 4 months;
•3\) smoke cigarettes bidi
•4\) have current substance abuse (e.g., opioids, cocaine, marijuana) verified by urine drug screen;
•5\) have current (last 6\-months) alcohol consumption that exceeds 25 standard drinks/week (if past abuse, must be symptom free for Ã¢â?°Â¥ the past 12 months);
•6\) Current use or discontinuation within last 14 days of:
•a.smoking cessation medications (bupropion, Chantix, NRT);
•b.antipsychotics, atypicals, mood\-stabilizers, anti\-depressants (tricyclics, SSRIs, MAOIs), anti\-panic agents, anti\-obsessive agents, anti\-anxiety agents, stimulants;
•c.Anti\-coagulants;